Ameditech DrugSmart 12 Test Cup Recall for Reduced Benzodiazepine Reactivity
Ameditech is recalling DrugSmart 12 Test Cups because they may show reduced reactivity for two specific benzodiazepine compounds.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which by definition is unlikely to cause adverse health consequences, and the issue is a performance defect (reduced reactivity) rather than a direct physical hazard.
Plain-English summary
Ameditech Inc is recalling 160 kits of DrugSmart 12 Test Cup (Multi & BUP), Item No. 61210D, and DrugSmart 12 Test Cup (Multi/Single/BUP), Item No. 61205D. The affected products were distributed nationwide.
The recall was initiated because the tests have shown reduced reactivity for up to two of the nineteen benzodiazepine compounds listed in the product insert. The specific compounds for which reactivity may be reduced are Clonazepam and Chlordiazepoxide. This issue may affect the accuracy of test results for these specific substances.
Consumers should stop using the affected test cups and contact Ameditech Inc for further instructions or a refund.
The recalled product
- Product
- DrugSmart 12 Test Cup (Multi & BUP), Item No. 61210D DrugSmart 12 Test Cup (Multi/Single/BUP), Item No. 61205D
- Manufacturer
- Ameditech Inc
- Affected units
- 160
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- 152736 143864 150204 151981
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 59 recalled by Ameditech Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 59 products in this recall →Related recalls
Same manufacturer · Ameditech Inc
See all →- ModerateAmeditech Noble 1 Step+ Cup Recalled for Inconsistent Performance
FDA (Devices) · 2020-10-07
- ModerateAmeditech iCup Dx14 Drug Screen Cup Recalled for Performance Failures
FDA (Devices) · 2020-10-07
- HighAmeditech Recalls ImmuTest Drugs of Abuse Cups for Performance Failures
FDA (Devices) · 2020-10-07
- ModerateAmeditech Fastect II Drug Screen Dipstick Tests Recalled for Performance Failures
FDA (Devices) · 2020-10-07
- ModerateAmeditech Recalls One Step + DOA Cup Due to Performance Failures
FDA (Devices) · 2020-10-07
Same hazard · reduced reactivity
See all →- ModerateSerology ToRCH positive control specimen recalled for decreased HSV reactivity
FDA (Devices) · 2024-01-10
- LowAmeditech DrugSmart Dip Benzodiazepine Test Recall for Reduced Reactivity
FDA (Devices) · 2015-12-30
- ModerateAmeditech ProScreen 6 Panel Dip Card Recall for Reduced Benzodiazepine Reactivity
FDA (Devices) · 2015-12-30
- ModerateAmeditech ProScreen 5 Panel Dip Card Recalled for Reduced Benzodiazepine Reactivity
FDA (Devices) · 2015-12-30
- ModerateAmeditech ProScreen 12 Drug Cup Recall for Reduced Benzodiazepine Reactivity
FDA (Devices) · 2015-12-30